Evidence map›Paper›PMID 21479313›Full record

ReviewPhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2011

Combination approaches to potentiate immune response after photodynamic therapy for cancer.

Tyler G St Denis, Kanza Aziz, Anam A Waheed, Ying-Ying Huang, Sulbha K Sharma, Pawel Mroz, Michael R Hamblin

Abstract readReview
In one paragraph

Review in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Photobiomodulation of breast and cervical cancer stem cells using low-intensity laser irradiation.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2017
    Article
  12. Review
  13. Review
  14. T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2015
    Article
  15. Article
  16. Article
  17. Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.Integrative biology : quantitative biosciences from nano to macro · 2013
    Article
  18. Review
  19. Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Tyler G St DenisWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Kanza Aziz
Anam A Waheed
Ying-Ying Huang
Sulbha K Sharma
Pawel Mroz
Michael R Hamblin
Massachusetts General Hospital · USAga Khan University · PKHarvard–MIT Division of Health Sciences and Technology · USHarvard University · US

Funding

DERMATOLOGY TRAINING GRANTT32AR007098 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI THOMAS S. KUPPER · 1986 to 2026
$8.1M
Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
NIAID NIH HHS R01 AI050875NIAID NIH HHS R01AI050875NIAID NIH HHS R01CA/AI838801NIAMS NIH HHS T32 AR007098
6 · The paper itself

Abstract

Photodynamic therapy (PDT) has been used as a cancer therapy for forty years but has not advanced to a mainstream cancer treatment. Although it has been shown to be an efficient way to destroy local tumors by a combination of non-toxic dyes and harmless visible light, it is its additional effects in mediating the stimulation of the host immune system that gives PDT great potential to become more widely used. Although the stimulation of tumor-specific cytotoxic T-cells that can destroy distant tumor deposits after PDT has been reported in some animal models, it remains the exception rather than the rule. This realization has prompted several investigators to test various combination approaches that could potentiate the immune recognition of tumor antigens that have been released after PDT. This review will cover these combination approaches using immunostimulants including various microbial preparations that activate Toll-like receptors and other receptors for pathogen-associated molecular patterns, cytokines growth factors, and approaches that target regulatory T-cells. We believe that by understanding the methods employed by tumors to evade immune response and neutralizing them, more precise ways of potentiating PDT-induced immunity can be devised.

Indexed as

PhotochemotherapyAdjuvants, ImmunologicHumansNeoplasmsPhotosensitizing AgentsT-Lymphocytes, CytotoxicAdjuvants, ImmunologicPhotosensitizing Agents

Identifiers

PMID21479313
PMCPMC3449163
OpenAlexW2001712382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.